These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 26596412)
1. Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups. Kim Y; Hong M; Do IG; Ha SY; Lee D; Suh YL Pathol Res Pract; 2015 Dec; 211(12):963-72. PubMed ID: 26596412 [TBL] [Abstract][Full Text] [Related]
2. ROR2 and Wnt5a expression in stage 1 pure testicular seminomas. Lim SD; Kim WS; Kwon GY Anal Quant Cytopathol Histpathol; 2013 Feb; 35(1):41-51. PubMed ID: 23469623 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of Ror2 and Wnt5a expression in medulloblastoma. Lee SE; Lim SD; Kang SY; Suh SB; Suh YL Brain Pathol; 2013 Jul; 23(4):445-53. PubMed ID: 23278988 [TBL] [Abstract][Full Text] [Related]
4. Immunoreactivity of Wnt5a, Fzd2, Fzd6, and Ryk in glioblastoma: evaluative methodology for DAB chromogenic immunostaining. Hirano H; Yonezawa H; Yunoue S; Habu M; Uchida H; Yoshioka T; Kishida S; Kishida M; Oyoshi T; Fujio S; Sugata S; Yamahata H; Hanaya R; Arita K Brain Tumor Pathol; 2014 Apr; 31(2):85-93. PubMed ID: 23748645 [TBL] [Abstract][Full Text] [Related]
5. Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer. Lu C; Wang X; Zhu H; Feng J; Ni S; Huang J Oncotarget; 2015 Sep; 6(28):24912-21. PubMed ID: 26305508 [TBL] [Abstract][Full Text] [Related]
6. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis. Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546 [TBL] [Abstract][Full Text] [Related]
7. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells. Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266 [TBL] [Abstract][Full Text] [Related]
8. Wnt5a and Ror2 expression associate with the disease progress of primary thyroid lymphoma. Wang L; Yang D; Wang YH; Li X; Gao HM; Lv JY; Wang L; Xin SJ Tumour Biol; 2016 May; 37(5):6085-90. PubMed ID: 26608372 [TBL] [Abstract][Full Text] [Related]
9. Comparative study of ROR2 and WNT5a expression in squamous/adenosquamous carcinoma and adenocarcinoma of the gallbladder. Wu ZC; Xiong L; Wang LX; Miao XY; Liu ZR; Li DQ; Zou Q; Liu KJ; Zhao H; Yang ZL World J Gastroenterol; 2017 Apr; 23(14):2601-2612. PubMed ID: 28465645 [TBL] [Abstract][Full Text] [Related]
10. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells. Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592 [TBL] [Abstract][Full Text] [Related]
11. Spinal Wnt5a Plays a Key Role in Spinal Dendritic Spine Remodeling in Neuropathic and Inflammatory Pain Models and in the Proalgesic Effects of Peripheral Wnt3a. Simonetti M; Kuner R J Neurosci; 2020 Aug; 40(35):6664-6677. PubMed ID: 32616667 [TBL] [Abstract][Full Text] [Related]
12. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration. Nishita M; Yoo SK; Nomachi A; Kani S; Sougawa N; Ohta Y; Takada S; Kikuchi A; Minami Y J Cell Biol; 2006 Nov; 175(4):555-62. PubMed ID: 17101698 [TBL] [Abstract][Full Text] [Related]
17. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling. Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643 [TBL] [Abstract][Full Text] [Related]
18. Ryk is essential for Wnt-5a-dependent invasiveness in human glioma. Habu M; Koyama H; Kishida M; Kamino M; Iijima M; Fuchigami T; Tokimura H; Ueda M; Tokudome M; Koriyama C; Hirano H; Arita K; Kishida S J Biochem; 2014 Jul; 156(1):29-38. PubMed ID: 24621529 [TBL] [Abstract][Full Text] [Related]
19. RYK promotes the stemness of glioblastoma cells via the WNT/ β-catenin pathway. Adamo A; Fiore D; De Martino F; Roscigno G; Affinito A; Donnarumma E; Puoti I; Ricci Vitiani L; Pallini R; Quintavalle C; Condorelli G Oncotarget; 2017 Feb; 8(8):13476-13487. PubMed ID: 28086236 [TBL] [Abstract][Full Text] [Related]
20. The clinical pathological significance of FRAT1 and ROR2 expression in cartilage tumors. He L; Yang Z; Zhou J; Wang W Clin Transl Oncol; 2015 Jun; 17(6):438-45. PubMed ID: 25387569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]